A recent study of CD133-expressing tumour cells isolated from human glioma xenografts and primary glioblastomas reported that the CD133+ tumour cells may represent the population that confers glioma radiation resistance (Bao et al, 2006). Here, PROM1 is linked to glioblastoma.